Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Aug 2026 for Iovance Biotherapeutics, INC., €13k. Read the official filing
Filing timeline
BuySaleDaniel Gordon Kirby
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +81.0%Entry US$2.21 · Close at T+365 US$4.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Daniel Gordon Kirby: trading record in brief
All filings by Daniel Gordon Kirby on record concern Iovance Biotherapeutics, Inc. Over a trading history stretching from 5 June 2025 to 10 August 2026, the count stands at 5 filings.
The open-market record is one-sided, with 1 purchase worth €48k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant and 3 option exercises.
The latest filing, published on 12 August 2026, reports a share grant of €13k in Iovance Biotherapeutics, Inc. The last purchase on record was published on 6 June 2025, which is 499 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Daniel Gordon Kirby
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
2,436 shares@ US$6.400.0003% mcap21.9% of flowCommon StockSEC:0001104659-26-095040:1
10,001 shares0Common StockSEC:0001104659-26-095040:0
120,000 shares0Common StockSEC:0001104659-26-020613:0
39,996 shares0Common StockSEC:0001104659-26-014400:0
30,000 shares@ US$1.8478.1% of flowCommon StockSEC:0001104659-25-057310:0
Canonical exit: 3 Sept 2025 (T+90)
5 of 5 declarations
